Notify me when Inspire Investing, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 846 | $1.03B | +$177M | -$141M | +$36M | CAT, ANET, APH, SCHO, IBD | 13F-HR | 10/15/2025, 03:37 PM |
| Q2 2025 | 824 | $918M | +$166M | -$139M | +$27.2M | CAT, WWJD, SCHO, PGR, APH | 13F-HR | 7/24/2025, 04:10 PM |
| Q1 2025 | 800 | $841M | +$170M | -$195M | -$24.4M | SCHO, PGR, WWJD, CAT, IBD | 13F-HR | 6/3/2025, 01:40 PM |
| Q4 2024 | 824 | $894M | +$99.3M | -$155M | -$55.7M | USFR, ISRG, CAT, WWJD, ANET | 13F-HR | 1/17/2025, 04:13 PM |
| Q3 2024 | 827 | $977M | +$211M | -$150M | +$60.2M | SMCI, IBD, CAT, USFR, ISRG | 13F-HR | 10/10/2024, 03:44 PM |
| Q2 2024 | 802 | $868M | +$93.1M | -$171M | -$78M | IBD, USFR, CAT, ISRG, WWJD | 13F-HR | 8/12/2024, 05:01 PM |
| Q1 2024 | 787 | $975M | +$176M | -$173M | +$2.28M | CAT, USFR, ISRG, IBD, PGR | 13F-HR | 5/7/2024, 04:51 PM |
| Q4 2023 | 785 | $909M | +$128M | -$87.6M | +$40.4M | IBD, USFR, CAT, NOW, WWJD | 13F-HR | 2/12/2024, 02:43 PM |
| Q3 2023 | 791 | $783M | +$148M | -$93.1M | +$54.9M | IBD, USFR, CAT, NOW, PLD | 13F-HR | 10/26/2023, 11:59 AM |
| Q2 2023 | 788 | $827M | +$130M | -$92M | +$38.5M | IBD, USFR, ISRG, PLD, NOW | 13F-HR | 7/31/2023, 10:23 AM |
| Q1 2023 | 781 | $785M | +$116M | -$75.4M | +$40.4M | USFR, IBD, PLD, ADI, NOW | 13F-HR | 4/24/2023, 10:24 AM |
| Q4 2022 | 743 | $777M | +$82.9M | -$21.6M | +$61.3M | TFLO, USFR, IBD, WWJD, BLES | 13F-HR | 1/26/2023, 01:28 PM |
| Q3 2022 | 754 | $708M | +$138M | -$94.2M | +$43.4M | USFR, TFLO, IBD, UUP, WWJD | 13F-HR | 11/7/2022, 04:01 PM |
| Q2 2022 | 762 | $754M | +$171M | -$47.4M | +$123M | USFR, IBD, UUP, WWJD, BLES | 13F-HR | 8/10/2022, 12:37 PM |
| Q1 2022 | 788 | $864M | +$155M | -$57M | +$97.7M | VGSH, IBD, PHYS, BLES, WWJD | 13F-HR | 4/21/2022, 10:10 AM |
| Q4 2021 | 785 | $861M | +$119M | -$43.8M | +$75.1M | IBD, VGLT, ISRG, NOW, PLD | Restatement | 2/14/2022, 09:02 AM |
| Q3 2021 | 794 | $791M | +$422M | -$359M | +$63.5M | IBD, VGLT, ISRG, NOW, BLES | 13F-HR | 11/9/2021, 02:02 PM |
| Q2 2021 | 593 | $760M | +$113M | -$48.6M | +$64.7M | NVDA, IBD, BLES, VGLT, ISMD | 13F-HR | 8/10/2021, 04:58 PM |
| Q1 2021 | 597 | $652M | +$237M | -$75.9M | +$161M | NVDA, IBD, VGIT, BLES, ISMD | 13F-HR | 4/30/2021, 12:07 PM |
| Q4 2020 | 622 | $452M | +$140M | -$42.1M | +$97.9M | IBD, BLES, NVDA, ISMD, WWJD | 13F-HR | 2/12/2021, 01:47 PM |
| Q3 2020 | 432 | $363M | +$119M | -$17.7M | +$102M | VGIT, IBD, BLES, NVDA, WWJD | 13F-HR | 11/16/2020, 03:27 PM |
| Q2 2020 | 485 | $290M | +$60.3M | -$25.1M | +$35.2M | IBD, BLES, WWJD, ISMD, BIBL | 13F-HR | 8/12/2020, 03:46 PM |
| Q1 2020 | 735 | $250M | +$76.5M | -$34.9M | +$41.5M | IBD, BLES, WWJD, ISMD, BIBL | 13F-HR | 5/8/2020, 04:44 PM |
| Q4 2019 | 351 | $279M | +$20.3M | -$14.5M | +$5.83M | IBD, BLES, ISMD, BIBL, WWJD | 13F-HR | 1/24/2020, 11:28 AM |
| Q3 2019 | 375 | $262M | +$38.7M | -$3.4M | +$35.3M | IBD, BLES, ISMD, BIBL, UNP | 13F-HR | 11/13/2019, 01:18 PM |
| Q2 2019 | 328 | $238M | +$30M | -$8.87M | +$21.1M | IBD, BLES, ISMD, BIBL, UNP | 13F-HR | 7/16/2019, 01:32 PM |
| Q1 2019 | 297 | $215M | +$56M | -$4.65M | +$51.3M | IBD, BLES, ISMD, BIBL, ABBV | 13F-HR | 5/16/2019, 07:42 AM |
| Q4 2018 | 242 | $149M | +$14M | -$1.03M | +$13M | BLES, IBD, ISMD, BIBL, ABBV | Restatement | 2/21/2019, 05:01 PM |
| Q3 2018 | 237 | $162M | +$20.8M | -$1.75M | +$19M | BLES, IBD, ISMD, BIBL, NVDA | Restatement | 2/21/2019, 04:59 PM |
| Q2 2018 | 220 | $141M | +$42.1M | -$489K | +$41.6M | BLES, IBD, ISMD, BIBL, ABBV | Restatement | 2/21/2019, 04:59 PM |
| Q1 2018 | 199 | $98.2M | +$17.4M | -$40.2K | +$17.3M | BLES, IBD, ISMD, BIBL, ITW | Restatement | 2/21/2019, 08:04 PM |
| Q4 2017 | 869 | $117M | BLES, IBD, ISMD, BIBL, JNPR | Restatement | 2/21/2019, 04:49 PM |